AlphaStocks
3.1
Weak

Organon & Co. (OGN)

Health Care / Pharmaceuticals

S&P SmallCap 600

$6.14

Scores poorly across most models. Proceed with caution.

Weak

Score based on 5 of 5 models — high confidence

#993out of 1127 in Health Care

Is Organon & Co. a Good Investment in 2026?

Organon & Co. (OGN) scores 3.1 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Greenblatt Magic Formula model rates Organon & Co. as Strong (Top half (rank 35%)). The Lynch model is the least favorable, rating it Neutral. Organon & Co. ranks #993 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E8.6ROE15.4Market Cap2BDiv Yield5.9

Valuation

Trades at 9x earnings — near sector median of 25x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Neutral

Business quality & competitive moat

Graham

Attractive

31% below fair value

Lynch

Neutral

PEG 0.0 · Fast Grower

Greenblatt

Strong

Top half (rank 35%)

Frequently Asked Questions

Is Organon & Co. (OGN) a good investment?
Based on AlphaStocks' composite analysis, Organon & Co. (OGN) scores 3.1 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trades at 9x earnings — near sector median of 25x.
What is Organon & Co.'s Piotroski F-Score?
Organon & Co.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is OGN overvalued or undervalued?
A precise fair value estimate is not available for OGN. Trades at 9x earnings — near sector median of 25x.
How does OGN compare to other Health Care stocks?
Organon & Co. ranks #993 out of 1127 stocks in the Health Care sector, placing it in the top 88% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about OGN?
AlphaStocks evaluates OGN using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Attractive; Lynch: Neutral; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 3.1/10.

Similar Stocks

PARRFTIAZN

Compare OGN with

OGN vs PARROGN vs FTIOGN vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer